Company News

bioMérieux and JMI Labs partner against antimicrobial resistance (AMR)

bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.

March 8 – and every day –, let’s #EmbraceEquity

At bioMérieux, we support the inclusion, well-being and development of our team members and are committed to creating a culture of belonging and acceptance where all feel respected, supported and included.

2022: a fruitful year of CSR achievements

We are committed to play our part and as every gesture counts to change the game, we have implemented a number of concrete actions in line with our CSR objectives.

bioMérieux launches a PCR kit for detection of the monkeypox virus

bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world.

bioMérieux and InDevR partnership

bioMérieux is making a $5 million investment in InDevR, and will be the exclusive distributor in Europe of VaxArray®, a state-of-the-art vaccine quality control platform developed by the American company.